Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17077598 | 0.72 | LPO (0.33) | HTT | |
| SCHEMBL27929513 | 0.71 | HSF1 (0.34) | ALDH1A1POLBKMT2A | |
| SCHEMBL8866053 | 0.70 | ALDH1A1 (0.51) | ALDH1A1POLBKMT2ATLR8LMNA | |
| SCHEMBL10005373 | 0.68 | ALDH1A1 (0.74) | ALDH1A1POLBKMT2ATLR8LMNA | |
| SCHEMBL4132663 | 0.67 | ALDH1A1 (0.61) | ALDH1A1POLBKMT2ATLR8LMNA | |
| SCHEMBL5284763 | 0.67 | TSHR (0.38) | ALDH1A1POLBKMT2ATSHRGAA | |
| SCHEMBL329177 | 0.67 | ALDH1A1 (1.00) | ALDH1A1POLBKMT2ATLR8LMNA | |
| SCHEMBL28276561 | 0.67 | ALDH1A1 (1.00) | ALDH1A1POLBKMT2ATLR8LMNA | |
| SCHEMBL16607611 | 0.65 | ALDH1A1 (0.63) | ALDH1A1POLBKMT2ATLR8LMNA | |
| SCHEMBL2936161 | 0.65 | ALDH1A1 (0.69) | ALDH1A1POLBKMT2ATLR8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | PGLS, INMT, PNMT | ALDH1A1 4028/4885POLB 697/4885KMT2A 1556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.